$VDRM Low SS Pharma Stock! Innovative products al
Post# of 25417
Posted On: 03/21/2016 11:27:55 AM
$VDRM Low SS Pharma Stock! Innovative products already on the market. Just a matter of time. Getting accumulated now at cheap prices. Read stats here.. do your own DD. I am long on this one. I feel it has huge potential! Not a fake company like so many in OTC land. No fluff!
$VDRM 0049!!? IS THE BEST PRODUCT VS PRICE in the whole country. THE BEST PENNYSTOCK IN America, and COULD BE THE pharmacy stock of the year. This stock can run 30,000% here's why.
1) EXTREMELY OVERSOLD and unknown
2) ONLY 150 MILLION A\S! Makes it the TINIEST FLOAT VS PRICE out of ALL pharmacy stockso in the whole country!
3) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER.
4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.
4) INSIDERS OWN 75 MILLION SHARES, that's right 75 MILLION!
5) WON AWARD FOR THEIR DRUG
6) STRONG HANDS HOLDING 11 million shares out of the TINY 18 million float.
7) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.
THEY HAVE A PATENT which big boys have to be eyeing.
FELLAS PLEASE...PLEASE DO SOME RESEARCH ON THIS DRUG. VDRM IS A HIDDEN GOLDMINE
Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results.
Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity.
Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
Eczema- $2.5 billion in 2014
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products.
Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life.
Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher.
VDRM transdermal technology was used in a product which received the Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City
Named the winner of the “Drug Store News Best New Product” as voted by key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, NC.
Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing.
THIS IS NOT A REGULAR PENNY STOCK fellas. The LOWEST FLOAT vs price vs ALL PHARMA STOCKS IN THE COUNTRY. BIG BOARD OR OTC LAND. ALL OF THEM. Pharma stocks have the HIGHEST percentage gain in big boards or penny stocks.
Look at their product. LOOK AT WHAT THIS DRUG CAN DO! This is liquid gold IMO. The drug is unknown the stock is unknown but not for long http://www.viadermalicensing.com/img/ViaDermaCaseStudies.pdf
$VDRM 0049!!? IS THE BEST PRODUCT VS PRICE in the whole country. THE BEST PENNYSTOCK IN America, and COULD BE THE pharmacy stock of the year. This stock can run 30,000% here's why.
1) EXTREMELY OVERSOLD and unknown
2) ONLY 150 MILLION A\S! Makes it the TINIEST FLOAT VS PRICE out of ALL pharmacy stockso in the whole country!
3) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER.
4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.
4) INSIDERS OWN 75 MILLION SHARES, that's right 75 MILLION!
5) WON AWARD FOR THEIR DRUG
6) STRONG HANDS HOLDING 11 million shares out of the TINY 18 million float.
7) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.
THEY HAVE A PATENT which big boys have to be eyeing. FELLAS PLEASE...PLEASE DO SOME RESEARCH ON THIS DRUG. VDRM IS A HIDDEN GOLDMINE
Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results.
Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity.
Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
Eczema- $2.5 billion in 2014
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products.
Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life.
Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher.
VDRM transdermal technology was used in a product which received the Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City
Named the winner of the “Drug Store News Best New Product” as voted by key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, NC.
Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing.
THIS IS NOT A REGULAR PENNY STOCK fellas. The LOWEST FLOAT vs price vs ALL PHARMA STOCKS IN THE COUNTRY. BIG BOARD OR OTC LAND. ALL OF THEM. Pharma stocks have the HIGHEST percentage gain in big boards or penny stocks.
Look at their product. LOOK AT WHAT THIS DRUG CAN DO! This is liquid gold IMO. The drug is unknown the stock is unknown but not for long http://www.viadermalicensing.com/img/ViaDermaCaseStudies.pdf
(0)
(0)